Bahrain
9 Vaccines Approved for Use in Bahrain
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Approval Source: abcnews.go.com
Non Replicating Viral Vector
Gamaleya
Sputnik Light
Approved in 26 countries
7 trials in 3 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Serum Institute of India
Covishield (Oxford/ AstraZeneca formulation)
Approved in 49 countries
6 trials in 1 country
Approval Source: arabnews.com
Inactivated
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 93 countries
39 trials in 18 countries
Approval Source: nature.com
Inactivated
Valneva
VLA2001
Approved in 33 countries
9 trials in 4 countries
Approval Source: english.alarabiya.net
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Approval Source: reuters.com
2 in Clinical Trials in Bahrain
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 93 countries
39 trials in 18 countries
Inactivated
Sinopharm (Wuhan)
Inactivated (Vero Cells)
Approved in 2 countries
9 trials in 7 countries